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a b s t r a c t
The effects of MC-LR on antioxidant system in liver and kidney and its effects on hepatic
lipid composition after prolonged exposure to sublethal doses of microcystins (MCs) were
studied in mice. Mice were treated i.p. with 25 mg of MC-LR/kg body weight or saline
solution every 2 days for a month (inflictive stage), then progression or recovery was
studied for 1 and 2 months of wash-out. During the inflictive stage, MC-LR-induced
oxidative damage and significant changes in liver lipids of treated mice were compared
with control mice.
A clear dependence of the enzyme defense system was demonstrated with reduced
glutathione and a-tocopherol availabilities and a concomitant elevation in NOx
production.
Sub-chronic MC-LR toxicosis produced alterations in lipid components that included
a decreased EFA/non-EFA, SFA/PUFA, and n-3/n-6 ratios all of which exhibited a pattern of
slow recovery during the recovery periods.
 2009 Elsevier Ltd. All rights reserved.
1. Introduction
MCs are considered the most common group of cyano-
toxins in estuaries, ponds and water reservoirs associated
with acute, even lethal, toxicity in various species of
domestic animals, wildlife and humans (Falconer, 1999;
Jochimsen et al., 1998). Microcystins are cyclic heptapep-
tides consisting of seven amino acids, including several
D-amino acids and two unusual amino acids, namely the N-
methyldehydroalanine (Mdha) and hydrophobic b-amino
acid, 3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-
4,6-dienoic acid (Adda). Microcystin-LR (MC-LR) is the
most frequent, toxic and commonly studied isoform of
these hepatotoxins (WHO, 2004).
The mechanisms involved in chronic intoxication may
also be responsible for the increased incidence of primary
liver cancer in humans living in some areas of China
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Chronic exposure to sublethal concentrations of MCs is the
most common intoxication in wild and domestic animals
and humans (Ueno et al., 1996; Zhao et al., 2009).
It is known that the major route to MCs exposure is
through water intake. The stomach absorbs MC-LR to some
degree, but the main route of absorption is considered to be
the small intestine (Ito et al., 2000). The absorbed MCs were
taken up into the hepatocyte and to a lesser extent to other
cells by proteins transporters as the multi-specific bile acid
transporter (Bury et al., 1998).
Once in the cell, MCs induce toxicity in apparently
independent ways. (1) MCs are able to inhibit protein
phosphatases which in turn leads to cytoskeletal alter-
ations in liver and kidney (Solter et al., 1998; Codd, 1996;
Milutinovic et al., 2003), depletion of glycogen stores
(Guzman and Solter, 2002), inmunosupression (Chen et al.,
2004) and modify the activities of mitogen-activated
protein kinases (MAPK) that support tumour-promoting
activities (Pahan et al., 1998) and (2) MCs trigger the
production of reactive oxygen species (ROS), that in turn,
increase the formation of lipid peroxides (LPO) (Guzman
and Solter, 1999; Moreno et al., 2005; Andrinolo et al.,
2008), and induce mitochondrial damage, calpain release
and apoptosis (Ding and Ong, 2003).
An important effect on hepatocyte morphology
produced by prolonged exposure to MCs was the devel-
opment of cytoplasmic vacuoles in several hepatocites
(Solter et al., 1998; Andrinolo et al., 2008). According to this
study, a significant increase in hepatic lipid content and in
lipid peroxidation levels in liver and kidney tissue were
found in MC-LR treated animals when compared with
controls (Andrinolo et al., 2008). We hypothesized that an
additional hepatotoxic effect of prolonged exposure to MCs
is deranged lipid metabolism or induced fatty change, due
to the accumulative oxidative damage on lipidic compo-
nents of the cells.
Both ROS and LPO are known to be reduced by the
activity of antioxidant enzymes, such as GPX, GSH-Rd, CAT
and SOD (Packer et al., 1998) but little is known about the
specific response of antioxidant enzymes to MCs toxicosis.
An acute exposure to MC-LR results in a decrease in the
antioxidant enzymes and an increase in lipid peroxidation in
rats’ liver and kidney (Moreno et al., 2005). Recently, a study
showed that the antioxidant enzyme system responds
differently in organs such as the brain, kidney and liver after
a sub-chronic exposure at a lower dosage (Zhao et al., 2009).
For these reasons, we also aimed to investigate the changes
induced by MC-LR treatment on the antioxidant system in
liver and kidney during a sublethal chronic intoxication and
also during the recovering (wash-out) period.
Since the outcome of toxicity is determined by the
dynamic interplay between damage and its tissue repairing
response, we use an experimental model in which evident
damage is caused due to the i.p. administration of MC-LR
(stage 1) and then recovery or progression of the damage
was followed for two months without administration of
MC-LR (stage 2). Results obtained may contribute to the
understanding of the mechanisms of MC-LR-induced
damage on lipid cell composition, the temporal behaviour
of the toxicosis, and also the identification of putative
therapeutical targets.
2. Materials and methods
2.1. Chemicals
Pure oxidized and reduced glutathione, a-tocopherol,
NADþ, NADH(H), NADPH(H), thiobarbituric acid, N-ethyl-
maleimide, organic and inorganic components for buffer
preparations, sodium pyrophosphate, Tris (tris-hydroxy-
methyl-aminomethane), ATP (disodium salt), and pyro-
gallol were purchased from Sigma Chem. Co. (Buenos Aires,
Argentina). All solvents used were HPLC grade and provided
by Carlo Erba (Milano, Italy). Neutral and polar lipids, and
unlabelled fatty acids used as standards were obtained from
Serdary Research Lab. (London, Ontario, Canada) or Nu-
Check-Prep. (Elysian, MN). Other organic and inorganic
drugs used were of analytical grade and obtained from Fluka
Chemie AG, GmbH & Co. (Buenos Aires, Argentina).
2.2. Microcystin-LR purification
MC-LR was purified from natural blooms of Microcystis
aeruginosa collected at the Rio de la Plata basin by estab-
lished methods (Barco et al., 2005) with slight modifica-
tions. Firstly, cells were broken by 3 frozen–unfrozen
cycles, and the extract was cut with chloroform/methanol
(50:50; v:v). The aqueous fraction was concentrated in
a rotovapor (Decalab, R-23, Buenos Aires, Argentina).
Finally, the purification was performed with a semi-
preparative high performance liquid chromatography. We
used a Hewlett–Packard apparatus (HP 1100, USA) with
a degassed module and a diode array detector system. The
preparative column used was TERMO Hyperprep HS C18
(25010 mm), and the mobile phase was phosphate
buffer (pH 7.0) with 30% acetonitrile, run in isocratic
conditions at 5 ml/min. Detection was performed at
238 nm. The peak corresponding to MC-LR was collected
separately, concentrated and desalted with a C18 cartridge,
previously activated. Pure MC-LR was eluted with a solu-
tion of methanol–water (90:10, v:v) and the methanol was
evaporated. The toxin was tested by HPLC-MS method
(Barco et al., 2005). Final identification and concentration
of MC-LR were achieved by comparison with a toxin
standard from Sigma Chemical Inc. (St. Louis, MO).
2.3. Mice and treatment
Twenty four male mice N:NIH-S (20–22 g) with specific-
pathogen-free certified status were obtained from the
Animal Care Facility Unit of the Veterinary Medicine School
of La Plata National University. They were housed in plastic
cages (four animals in each) and fed ad libitum with
balanced food (Alimentos Ganave, Rosario, Argentina) and
water. Animals were maintained on a 12-h-light/darkness-
cycle and allowed to acclimatize to their surrounding
conditions (well-ventilated room maintained at 231 C)
for 1 week before experiments started. All animals received
human care and studies were conducted in accordance
with international protocols for laboratory animal care
(National Research Council, 1985). Experimental designs
were also approved by the local standard for protecting
animal’s welfare.
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2.4. Experimental design
Mice were divided at random into six groups. Treated
animals (three groups) were injected (300 ml) i.p. every
48 h during 1 month at a dose of 25 mg of MC-LR/kg body
weight. The toxin was freshly prepared by dilution of the
stock preparation with saline solution (0.9%; w/v). Control
groups of animals were injected with equivalent volume of
saline solution. After treatment (30 days for group 1), and
after one month (group 2), and two months (group 3)
without exposure to the toxin (wash-out periods), mice
from the treated and the corresponding control group were
slightly anesthetized with ether and they were euthana-
tized to obtain livers and kidneys. To minimize diurnal
variations, animals were routinely killed between 12:00
and 13:00 h. After washing and weighing, both tissues were
placed on ice-cold buffered solution (140 mM sodium
phosphate, 0.1 mM EDTA, pH 7.40) (Marra et al., 1986),
decapsulated, and homogenized by means of a glass-teflon
homogenizer (Kontes Glass Company, Vineland, NJ). Cell
debris and nuclei were removed by centrifugation at
10,000 g (20 min at 1–2 C) in a Sorvall RC5C Dupont
centrifuge (Newtown, CT). Supernatants were aliquoted
and frozen in hermetic polypropylene vials at70 C under
N2 atmosphere until used for experimental measurements.
Appropriate aliquots of samples were treated immediately
with 40 mM N-ethylmaleimide and precipitated with TCA




Individual lipid subclasses were quantified by a densi-
tometric procedure (Marra and de Alaniz, 1992) using the
1D Image Analysis Software, Windows ver. 2.0.3 from
Eastman Kodak Company (Rochester, NY). Cholesterol
content was enzymatically measured according to Allain
et al. (1974). Triacylgliceride (TG) content was assayed
using a kit from Wienner Lab. (Rosario, Argentina). Total
fatty acid methyl esters (FAMEs) were prepared with 14%
(W/V) boron trifluoride-methanol following the method of
Morrison and Smith (1964) and analyzed by capillary gas–
liquid chromatography (c-GLC) in a Hewlett Packard HP
6890 Series GC System Plus (Avondale, PA) equipped with
a terminal computer integrator. Authentic standards of
FAMEs mixtures were routinely run to check the identity of
the fatty acids analyzed by means of relative retention
times. In some cases, the identity of the fatty acids was
confirmed by means of mass-spectrometry analysis (Marra
et al., 2002). A standard procedure for a single-step prep-
aration of dimethyl disulfide adducts of the fatty acids was
performed according to Yanamoto et al. (1991). Gas–liquid
mass-spectrometry analysis of the fatty acid adducts was
carried out on a glass column (1 m 3 mm i.d.) packed
with 2% OV-101 on 100-200 mesh Chromosorb WHP
(Supleco, Bellefonte, PA) in a Hitachi 663-30 gas chro-
matograph linked to a Hitachi M-80A Double-focusing
Mass Spectrometer (ionization energies from 20 to 70 eV)
with an M-003 minicomputer on-line system. Scan speed
was 5 s per cycle for 0–450 a.m.u. and the column
temperature was programmed at 2 C/min from 230 C to
260 C. Perfluorokerosene was used for calibration stan-
dard with a resolution power of approx. 6000.
2.5.2. Oxidative stress biomarkers
Contents of oxidized glutathione (GSSG) were deter-
mined following the method of Rahman et al. (2006),
whereas reduced glutathione (GSH) was measured
following the glutathione-S-transferase assay described by
Brigelius et al. (1983). Samples for glutathione analyses
were obtained in the presence of N-ethylmaleimide and
deproteinized (1:9, by vol.) using trichloroacetic acid (15%
final concentration) as recommended by Asensi et al.
(1994). Superoxide dismutase activities (SOD) were
assayed as described by Flohé and Ötting (1984). GPX, GSH-
Tr, and GSH-Rd were assayed according to Wheeler et al.
(2001), Habig et al. (1984), and Carlberg and Mannervick
(1985), respectively. Catalase activities were measured
according to the UV kinetic method of Aebi (1984). a-
Tocopherol contents were determined by HPLC following
the method of Buttris and Diplock (1984). HPLC analyses
were performed in a Merck–Hitachi apparatus (Darmstadt,
Germany) equipped with an L-6200 Solvent Delivery
System and an L-4200 UV/VIS Detector. We used a A-
250 4.6 mm Econosil C-18 column (Alltech Associates,
Deerfield, IL) coupled to a 10 4 mm guard column
(packed similarly) run isocratically at 1.5 mL/min. Nitrate
plus nitrite levels (NOx) were assayed by the enzymatic
method of Verdon et al. (1995). Protein content was
determined by the micromethod of Bradford (1976) with
crystalline BSA as standard.
2.6. Statistical treatment
All samples were processed individually. The data
represent the mean of 4 individual determinations (assayed
in duplicate or triplicate) 1 standard deviation (SD). The
statistical significance of data was analyzed by either the
Student’s t-test or by ANOVA (analysis of variance) plus
Bonferroni test, with the aid of Systat (version 12.0 for
Windows) from SPSS Science (Chicago, IL). Data were
plotted and analyzed using Sigma Scientific Graphing Soft-
ware (version 11.0) from Sigma Chem. Co. (St. Louis, MO)
and/or GB-STAT Professional Statistics Program (version 4.0)
from Dynamic Microsystems Inc. (Silver Springs, USA).
3. Results
3.1. Redox homeostasis
We first examined the impact of the sub-chronic expo-
sure to MC-LR on the oxidative stress biomarkers in mouse
liver and kidney homogenates. Fig. 1 shows the changes
observed in the glutathione reductase (GSH-Rd) activity
and superoxide dismutase (SOD, total activity) in both
tissues. After a 30-day period of MC-LR administration, we
observed a significant reduction in the activities of both
enzymes not only in liver but also in kidney homogenates.
We found an especially diminished SOD activity in kidney
preparations after the toxicosis. However, in all cases
enzymes were restored to control values after 1 month of
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the wash-out period. In the case of the livers, total SOD
activity increased significantly compared to control values
2 months after MC-LR deprivation (Fig. 1). Also, GPX and
CAT activities were affected by MC-LR administration
(Fig. 2). Once again, we found that both enzymes’ activity
was significantly decreased by MC-LR treatment. After
a month without toxin administration the activity of GPX in
kidney was restored to control values, while it continued
diminishing in liver preparation. CAT activity increased
significantly compared to control data after 1 month of the
wash-out period in both, liver and kidney homogenates.
The activities of both enzymes were normalized after 2
months without MC-LR treatment.
Levels of reduced (GSH) and oxidized (GSSG) gluta-
thione were deeply affected by MC-LR administration in
liver and kidney (Fig. 3). We observed that in both tissues
GSSG and GSH levels had increased and, as a result, the
additional GSHþGSSG also increased compared with
control values. The ratio GSH/GSSG was diminished due to
the higher increases of GSSG in comparison with those of
GSH. After 1 month of the wash-out period, all values
returned to control data except the total amount of liver
glutathione, which remained significantly elevated (Fig. 3).
Interestingly, after 2 months without toxin administration,
the only significantly elevated parameter was the ratio
GSH/GSSG in kidney. Fig. 4 shows that GSH-Tr activity
increased in liver preparations. The increase observed in
the kidneys was not statistically significant. After 1 month
of toxin suppression the enzyme activity was restored to
control values. Estimation of nitric oxide synthetase
activity by means of the production of [NOx] (nitrite plus
nitrate levels) was increased at the end of the treatment,
but it normalized after a 1 month wash-out period. We also
observed a significant decrease of a-tocopherol in the livers
(Fig. 5) that was restored to control values after 1 month of
toxin suppression.
3.2. MC-LR-induced changes on lipid composition
Fig. 6 shows the changes in the major liver lipid
subclasses after injecting MC-LR and during the wash-out






































Fig. 1. Glutathione reductase (GSH-Rd) and total superoxide dismutase
(SOD) activities in liver and kidney from control (white bars), and exposed
animals to MC-LR (25 mg/kg body weight) during 30 days (black bars), and
after 30 (gray bars) or 60 (dashed bars) days toxin suppression. Enzymes
were determined as described in Materials and methods section and were
expressed (units/mg protein) as the mean SD of four independent deter-
minations assayed in duplicate. *: Significantly different from the corre-








































Fig. 2. Glutathione peroxidase (GPX) and catalase (CAT) activities in liver
and kidney from control (white bars), and exposed animals to MC-LR (25 mg/
kg body weight) during 30 days (black bars), and after 30 (gray bars) or 60
(dashed bars) days toxin suppression. Enzymes were determined as
described in Materials and methods section and were expressed (units/mg
protein) as the mean SD of four independent determinations assayed in
duplicate. *: Significantly different from the corresponding control value
(p< 0.01).
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major lipid subclasses studied such as TAG, NEFA, PhtEth
and PhtChol. Cholesteryl esthers (ECHO) were significantly
reduced.
During the wash-out period, PhtEth level was restored,
and a reduction was observed in the elevation for PhtChol.
It is interesting to note that the increase induced by MC-LR
treatment on TAG levels was maintained, and increased
further, after the first month of the wash-out period (Fig. 6).
All the parameters normalized after the second month of
toxin suppression.
Quantitative main modifications induced by MC-LR
treatment on the fatty acyl composition of liver are shown
in Table 1. The toxin produced an increment in the absolute
quantity (mmol/mg protein) of all saturated fatty acids (SFA)
such as 18:0, 20:0, 22:0 and 24:0, with a concomitant
reduction of monoenoates, especially oleic acid (18:1) and
24:1. Within the polyunsaturated fatty acids (PUFA), major
changes were observed. Arachidonic acid (20:4 n-6) was
significantly reduced together with eicosatrienoate (its
direct metabolic precursor in the n-6 essential series). At
the same time, the 22:3 n-6 level dropped significantly
since it derived from the elongation pathway that initiates
in 20:3 n-6. Other changes were observed in the quantity of
superior homologues of the n-3 series: elevation of 21:5
and reduction in both 22:5 and 22:6. After one month of
toxin suppression, all the changes normalized, except those
observed for 20:3 and 20:4 of the n-6 series, 22:6 n-3, and
18:0. The elevation in the amount of stearic acid (18:0) was
even more evident compared to the values observed after
the one-month of toxin treatment (15 and 32% over control
data, respectively). At the end of the second month of the
wash-out period, the fatty acyl pattern was completely
normalized.
Table 2 shows some analytical parameters calculated
from data presented in Table 1. Main changes were
observed in the relative proportion of saturated to poly-
unsaturated fatty acyl chains. The toxin treatment induced
a significant reduction of PUFA due to SFA which was
directly correlated with a drop in the double bond index
(DBI). Even more interesting was the decrease in the ratio
n-3/n-6 which was diminished due to a proportionally
higher reduction of n-3 homologues compared to n-6
homologues (43 and 24% compared to the control data,
respectively). Another interesting point was the reduction
in the essential to non-essential fatty acid ratio (EFA/non-
EFA) since MC-LR administration was able to induce a sort
of ‘‘EFA deficit’’ not previously reported for this kind of
toxin. Proportions of SFA to PUFA – and consequently DBI –
remained altered after two months of toxin suppression.
However, the relative quantity of n-3 to n-6 fatty acyl
chains had a tendency to normalize after MC-LR
suppression.
We also analyzed the analytical parameters involved in
the elongation–desaturation routes that start with the
conversion of the 18:2 n-6 (linoleic) or 18:3 n-3 (linolenic)
essential fatty acids. The metabolic indexes (D5þD6) DIA,








































Fig. 3. Total (white bars), reduced (gray bars) and oxidized (black bars)
glutathione contents, and GSH/GSSG ratios (dashed bars) in liver and kidney
from control, exposed animals to MC-LR (25 mg/kg body weight), and toxin-
deprived mice. GSH and GSSG were determined as described in Materials
and methods section and were expressed (mmol/g of wet weight) as the
mean SD of four independent determinations assayed in triplicate.



















Fig. 4. Glutathione transferase (GSH-Tr) activity in liver and kidney from
control (white bars), and exposed animals to MC-LR (25 mg/kg body weight)
during 30 days (black bars), and after 30 (gray bars) or 60 (dashed bars) days
toxin suppression. Enzymes were determined as described in Materials and
methods section and were expressed (units/mg protein) as the mean SD of
four independent determinations assayed in duplicate. *: Significantly
different from the corresponding control value (p< 0.01).
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legend of Table 2. A significant decrease was observed in
(D5þD6) DIA at the end of the inflictive stage and at the
first month of wash out. D6 DIA showed a significant
decrease during the exposure period and a return to control
values after the first month of wash out. We observed
a significant decrease in D5 DIA index between treated
animals and control animals only in the first month of wash
out.
Nevertheless, no changes were found in (D5þD6) DIA,
D6 DIA, and D5 DIA after two month of wash out.
4. Discussion
In this study, our aim was to explore the causes of liver
and kidney damage induced by chronic treatment with low
doses of MC-LR. Our hypothesis is that an additional
hepatotoxic effect of MCs is to alter the lipid metabolism or
produce fatty change due to the accumulative effect of
oxidative damage when the exposure is prolonged.
4.1. Redox homeostasis
In agreement with a previous report on acute intoxica-
tion in rats (Moreno et al., 2005), and with a prolonged
exposure to MCs in rabbits (Zhao et al., 2009) we found
decreased levels of CAT, SOD, GPX and GSH-Rd in both liver
and kidney preparations from mice treated sub-chronically
with MC-LR. Reductions observed for the enzymes were of
similar magnitude in both tissues. However, the normali-
zation of the activities revealed a complex interaction
between these members of the antioxidant defense system
and the non-enzymatic scavengers.
The results of this work supported the idea that a natural
consequence of the SOD inhibition is a reduction in the
superoxide scavenging. In this way, excess of superoxide
may be the responsible for the inhibition of CAT and GPX
activity, which in turn, leads to a progressive accumulation
of peroxide (Moreno et al., 2005; Andrinolo et al., 2008) and
formation of OH. This oxygenated radical is highly reactive
against lipids, proteins, and DNA; and there are no scav-
enging mechanisms to neutralize it (Vranova et al., 2002).
Our results showed that sub-chronic exposure to MC-LR
results in an increase in NOx production in kidneys and
livers of mice and consequently excessive peroxynitrite
formation that may lead to both serious damage in the
redox homeostasis and disruption of sensitive biomole-
cules (especially lipids and nucleic acids) (Packer et al.,
1998). Consumption of a-tocopherol in liver could be the
consequence of this pro-oxidative situation that requires an
extra-amount of scavengers in the hydrophobic compart-
ment of the cell.
GPX remains decreased after the first month of the wash-
out period. SOD activity also increased in livers after the
second month of wash-out, and CAT was found to have















































Fig. 5. Nitric oxide synthetase activity (upper panel) estimated as the
production of nitrateþ nitrite [NOx] levels in liver and kidney from control
(white bars), and exposed animals to MC-LR (25 mg/kg body weight) during
30 days (black bars), and after 30 (gray bars) or 60 (dashed bars) days toxin
suppression. [NOx] was determined as described in the materials and
method section and were expressed (pmol/mg protein) as the mean SD of
four independent determinations assayed in triplicate. a-Tocopherol content
(lower panel) determined in the same preparations detailed before. Results
were expressed as nmole of tocopherol per mg total lipids and they were the
mean SD of four independent determinations assayed in triplicate.


























TAG2 CHO3  NEFA4 PhtChol1  PhtEth1   ECHO5
Fig. 6. Major lipid classes in total homogenates from control (white bars),
and exposed animals to MC-LR (25 mg/kg body weight) during 30 days (black
bars), and after 30 (gray bars) or 60 (dashed bars) days toxin suppression.
Each sample was collected and separately analyzed under the conditions
described in detail in Materials and methods section. Results are the mean of
4 independent determinations assayed in duplicate SD. Results are
expressed as: 1pmole inorganic phosphate/mg protein, 2pmole tripalmitine/mg
protein; 3pmole/mg protein; 4pmole of palmitate/mg protein; 5pmole of
lynoleyl-cholesterol/mg protein. Significant differences between exposed
animals and the corresponding control group were indicated with an
asterisk (p< 0.01 or less).
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recovery period. These findings may reflectextensive damage
in the antioxidant enzymatic system which were unable to
neutralize the ROS accumulated (especially superoxide and
peroxide) during the exposure period. As a consequence, both
tissues required extra activity of the enzymes (SOD and CAT)
in order to restore redox homeostasis. It is also conceivable
that there could be a sort of inertial deregulation of the
enzymes at some point in their genetic expression (Gehringer
et al., 2004) that may justify these over-stimulations once the
treatment was interrupted.
4.2. Glutathione pathway
Toxin-induced oxidative damage had a strong influence
on the glutathione metabolism. Glutathione is considered
a key non-enzymatic antioxidant within the polar
compartment of the cell and constitutes the first line of
protection against excessive ROS generation. Some authors
have suggested that a loss of reduced glutathione involved
in phase II reactions could represent the main route leading
the cells to oxidative stress (Moreno et al., 2005). There are
two main enzymes involved in the metabolic pathway of
glutathione transformation: GPX and GSH-Rd. A previous
paper reported that during acute intoxication with MC-LR,
GPX and GSH-Tr activities were significantly increased
together with an elevation in the total glutathione
concentration (Gehringer et al., 2004). In agreement with
these results, we also found an increase in the GSH-Tr
activity and in the total amount of glutathione. However,
the activity of GPX and GSH-Rd were reduced, under sub-
chronic exposure to the toxin. Liver tissue is considered
a main tissue involved in GSH biosynthesis and regulation
of redox homeostasis and as is well known, the liver is also
the target organ for MC-LR intoxication (Falconer, 1994).
It is known that GPX catalyzes the reduction of H2O2
using GSH. Thus, less availability of reduced glutathione
may be the natural consequence for a diminished GPX
activity in both tissues (liver and kidney). This result agreed
Table 1
Quantitative fatty acyl composition from control or exposed liver homogenates.
Fatty acids Treatment Wash-out periods
30 days 30 days 60 days
Control Exposed Control Exposed Control Exposed
14:0 0.1 0.01 0.2 0.03 0.2 0.01 0.3 0.05 0.1 0.0 Traces
15:0 0.2 0.02 0.1 0.0 0.1 0.0 0.2 0.03 0.2 0.03 0.1 0.01
16:0 21.1 0.5 23.5 0.6 19.1 0.3 22.5 0.5 20.1 0.7 19.9 0.5
16:1 (n-9) 2.2 0.1 2.0 0.1 1.8 0.2 2.3 0.2 1.9 0.1 2.2 0.3
16:1 (n-7) 0.2 0.01 0.1 0.02 0.1 0.01 Traces 0.2 0.03 0.3 0.1
17:0 0.6 0.03 0.4 0.04 0.7 0.1 0.5 0.1 0.8 0.1 0.7 0.2
16:3 (n-3) 0.2 0.01 0.3 0.0 0.3 0.05 0.2 0.03 0.2 0.0 0.2 0.05
16:4 (n-3) 0.1 0.0 0.2þ 0.03 0.3 0.03 0.2 0.0 0.4 0.1 0.3 0.01
18:0 18.8 0.7 21.4 0.6* 17.7 0.9 23.3 0.8* 18.5 0.6 22.2 0.3
18:1 (n-9) 15.1 0.3 11.5 0.3* 13.7 0.1 10.6 0.4 14.3 0.3 12.2 0.3
18:1 (n-7) 0.7 0.1 0.5 0.1 0.8 0.1 0.6 0.1 0.5 0.1 0.5 0.05
18:2 (n-7) 0.2 0.0 0.2 0.04 0.1 0.03 0.2 0.03 0.1 0.0 0.1 0.03
18:2 (n-6) 14.2 0.3 13.0 0.4 15.5 0.5 14.4 0.6 16.2 0.3 15.4 0.5
18:3 (n-6) 0.1 0.03 Traces 0.1 0.0 0.2 0.04 0.2 0.0 0.1 0.0
18:3 (n-3) 0.2 0.02 0.1 0.01 0.1 0.0 Traces 0.1 0.01 0.2 0.03
18:4 (n-3) 0.1 0.04 Traces 0.1 0.02 0.2 0.03 0.2 0.03 0.1 0.01
20:0 0.1 0.0 0.3 0.05* Traces 0.1 0.01 0.1 0.02 Traces
20:1 (
P
n-7þ n-9) 0.2 0.01 0.2 0.02 0.1 0.03 0.2 0.0 0.1 0.0 Traces
20:2 (n-6) 0.1 0.01 0.3 0.0* 0.1 0.0 0.1 0.02 Traces 0.1 0.03
20:3 (n-9) Traces 0.1 0.01 0.1 0.01 Traces 0.1 0.01 Traces
20:3 (n-6) 3.0 0.1 2.0 0.2* 2.7 0.1 2.0 0.1* 3.1 0.2 2.8 0.2
20:4 (n-6) 14.1 0.2 9.0 0.3* 15.4 0.6 10.3 0.4* 14.8 0.6 13.0 0.4
20:3 (n-3) 0.1 0.0 Traces Traces 0.2 0.05 0.1 0.0 0.2 0.02
20:4 (n-3) 0.2 0.03 0.1 0.01 0.1 0.02 Traces 0.2 0.01 0.1 0.0
20:5 (n-3) 0.1 0.0 Traces 0.2 0.03 0.1 0.01 0.1 0.02 Traces
22:0 0.2 0.03 0.4 0.01* 0.1 0.05 Traces 0.2 0.05 0.2 0.02
22:1 (n-9) 0.1 0.0 0.1 0.0 Traces 0.2 0.03 0.1 0.01 Traces
21:5 (n-3) Traces 0.1 0.03 Traces 0.1 0.0 0.1 0.03 0.2 0.05
22:2 (n-6) 0.1 0.02 Traces 0.1 0.01 Traces 0.2 0.03 0.1 0.0
22:3 (n-6) 0.3 0.02 0.1 0.02* 0.4 0.05 0.3 0.1 0.3 0.05 0.2 0.02
22:4 (n-6) Traces Traces 0.2 0.01 0.2 0.05 0.1 0.0 Traces
22:5 (n-6) 0.2 0.0 Traces 0.1 0.02 Traces 0.1 0.02 Traces
22:4 (n-3) 0.3 0.01 Traces 0.4 0.1 0.2 0.05 0.2 0.03 0.2 0.04
22:5 (n-3) 0.5 0.01 0.1 0.01* 0.3 0.02 0.1 0.03 0.4 0.1 0.3 0.05
24:0 0.1 0.0 0.3 0.02* 0.1 0.0 0.2 0.04 0.1 0.0 0.2 0.04
22:6 (n-3) 8.8 0.3 5.1 0.2* 9.2 0.4 6.1 0.2* 8.9 0.4 7.0 0.3
24:1 0.2 0.0 0.1 0.03* 0.1 0.0 Traces 0.2 0.04 0.2 0.0
c-GLC of the fatty acid methyl esters were performed as indicated in Materials and methods section. Samples from control or exposed liver homogenates
treated with saline, or toxin solution (25 mg/kg body weight), were separately analyzed (4 animals each group). Each value is expressed as mmol/mg total
protein (mean 1 SD). Results for the same fatty acid with an asterisk are significantly different (p< 0.01) compared to the corresponding control value.
Means below 0.1% are indicated as ‘‘traces’’. Other fatty acids not consigned in the table were present in negligible amounts. SD below 0.01 are indicated as
‘‘0.0’’.
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with previous reports suggesting the close dependence
between GPX activity and GSH levels (Gehringer et al.,
2004) but was contrary to that expected by Gehringer et al.
(2004) which claims that there is evidence that MC-LR to
causes an increase in the transcription of GPX. In our
findings the GPX remains inhibited during the whole
exposure time to MC-LR in kidney and liver. It remains
inhibited after a month of wash out in livers (Fig. 3). It was
also found that decreased GSH/GSSG levels are directly
correlated to diminished enzyme activity.
Another question to be considered from our results is
the fact that MC-LR can form a conjugated microcystin-GSH
as a sort of a detoxification process catalyzed by GSH-Tr
(Pflugmacher et al., 1998). In our experimental system this
fact was supported by the elevated levels of GSH-Tr
detected after the intoxication period. The conjugation of
GSH with MC-LR in an attempt to neutralize its toxicity,
also means that there is an important leak of this powerful
antioxidant from the available pool, leaving the tissues
even more susceptible to oxidative damage (Ding and Ong,
2003; Gehringer et al., 2004). In addition, a higher activity
of GSH-Tr in livers compared to kidneys may reflect the
main role that liver plays in detoxifying xenobiotics (like
MC-LR) through conjugation (Pflugmacher et al., 1998).
A similar pattern was observed for kidneys with the
exception of a persistent elevated ratio GSH/GSSG after the
second month of toxin suppression. This result may be
interpreted as a reestablishment of the reduced capacity of
the organ (without new biosynthesis of GSH) once ROS
accumulation was compensated. In livers, the equilibrium
between GSH and GSSG could be more rapid than in
kidneys due to the active metabolism of this antioxidant.
4.3. MC-LR-induced changes on lipid composition
We found that the redox dysfunction provoked by MC-
LR produced extensive damages in the fatty acyl pattern
and lipid composition of livers from intoxicated mice. To
our knowledge, this is the first time that such changes in
lipid composition due to MC-LR sub-chronic intoxication
have been reported. A loss of PUFA due to saturated fatty
acids should not be surprising due to the decreased sensi-
tivity that SFA showed for ROS-induced peroxidation (Yuan
et al., 1999). However, the fact that MC-LR can cause a fatty
acid like-deficiency (evidenced by a decreased EFA/non-
EFA ratio) was completely unexpected. EFA are important
precursors for the biosynthesis of prostaglandins, leuko-
trienes, tromboxanes, and other autacoids (de Alaniz and
Marra, 2003). Thus, MC-LR intoxication could be respon-
sible for alterations in the critical equilibrium among these
PUFA metabolites with relevant physiological properties.
More surprising was the finding that the proportions
between n-3 and n-6 fatty acyl chains were differentially
affected by the toxin. The decreased level of n-3 PUFAs
remained altered 30 days after suppression of the toxin.
This may be due to the fact that n-3 and n-6 PUFAs have
a protective (anti-oxidant) effect on oxidative-induced
damage (Eder et al., 2006).
We examined the analytical parameters involved in the
elongation–desaturation routes starting with the conver-
sion of the 18:2 n-6 (linoleic) or 18:3 n-3 (linolenic)
essential fatty acids. The metabolic indexes (D5þD6) DIA,
D6 DIA, and D5 DIA showed statistic differences between
treated and control animals indicating that the changes in
the fatty acyl pattern could be a consequence of (1)
Table 2
Analytical parameters from fatty acyl composition of total lipids of control and exposed animals.
Parameters Treatment Wash-out
30 days 30 days 60 days
Control Exposed Control Exposed Control Exposed
SFA 41.2 0.6 46.6 0.6* 38.0 0.9 47.1 0.8 40.1 0.7 45.5 0.5
PUFA 42.9 0.3 30.7 0.6* 45.8 0.6 35.1 0.6 46.1 0.6 40.6 0.5
DBIa 1.04 0.01 0.66 0.02 1.20 0 0.74 0.02 1.15 0.1 0.89 0.2
Total (n-3) 10.6 0.3 6.0 0.2 11.0 0.4 7.4 0.2 10.9 0.4 8.8 0.3
Total (n-6) 32.1 0.3 24.4 0.3 34.6 0.6 27.5 0.6 35.0 0.6 31.7 0.5
(n-3)/(n-6) 0.33 0 0.24 0 0.32 0.01 0.57 0.01 0.31 0.03 0.27 0.04
EFA/non-EFAb 0.72 0.01 0.50 0.01 0.84 0.03 0.57 0.03 0.8 0.01 0.67 0.02
ED 18:2 (n-6)c 1.22 0.01 0.85 0.02 1.17 0.05 0.85 0.02 1.11 0.10 1.03 0.03
ED 20:4 (n-6)d 0.01 0 – 0.02 0 0.02 0 0.01 0 –
(D6þD5) DIAe 0.99 0 0.69 0.01 0.99 0.02 0.72 0.01 0.91 0.02 0.84 0.02
(D6) DIAf 0.21 0.01 0.15 0 0.17 0 0.14 0.02 0.19 0.01 0.18 0.01
(D5) DIAg 4.7 0.11 4.5 0.05 5.7 0.14 5.15 0.21 4.77 0.15 4.64 0.10
PDAIh 9.45 0.32 –* 0.01 0 – 0.01 0 0.02 0
SDAIi 0.80 0.02 0.54 0.01 0.77 0.01 0.45 0.03 0.77 0.02 0.55 0.03
Results were expressed as the mean 1 SD of 4 independent determinations obtained from data of Table 1. Calculations for parameters a, b, f, h, and i were
done according to Lepage et al. (1989); c, and d, were calculated according to Martı́nez and Ballabriga (1987). * Significantly different respect to the cor-
responding control values. Amounts below 0.01 are indicated as ‘‘–’’. SD< 0.01 is indicated as ‘‘0’’.
a PUFA/saturated.
b (n-6)þ (n-3)/(n-7)þ (n-9)þ saturated.
c 20:3 (n-6)þ 20:4 (n-6)þ 22:5 (n-6)/18:2 (n-6).
d 22:4 (n-6)þ 22:5 (n-6)/20:4 (n-6).
e 20:4 (n-6)/18:2 (n-6).
f 20:3 (n-6)/18:2 (n-6).
g 20:4 (n-6)/20:3 (n-6).
h 16:1 (n-7)/16:0.
i 18:1 (n-9)/18:0.
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a differential destruction by peroxidation rather than
alterations in the biosynthetic pathways, (2) a modification
in the fatty acyl elongases and/or desaturases enzymes
activities due to a direct or indirect action of the toxin, or
(3) a combination of both effects. However, to our knowl-
edge, there are no previous experimental data concerning
MC-LR-induced changes on enzymes of the fatty acid
metabolism. This possible effect remains to be investigated.
Thus, it is likely that the modifications observed on the
analytical indexes may result from the destruction of PUFAS
by lipid peroxidation under the redox imbalance evoked by
the toxin. In addition, analyzing the results of Tables 1 and
2, a very interesting question is evident. The analytical data
that correspond to the wash-out period were completely
normalized after two months of toxin suppression while
the metabolic indexes remain altered. Thus, these calcula-
tions may be relevant in demonstrating that relative rather
than absolute alterations between the members of both
fatty acid series could be relevant to interpret the damage
induced by the MC-LR on cellular lipids.
Our findings also clarify the question why MC-LR toxi-
cosis decreases the fluidity of biological membranes (Her-
mansky and Stohs, 1991) since this property is directly
associated to PUFA contents and DBI values (Valentine and
Valentine, 2004).
In conclusion, our results show that chronic exposure to
MC-LR generates a deep pro-oxidative situation, with
involvement of NO, and an over saturation in the endoge-
nous antioxidant defense system that results in hepatic
lipid composition changes. These results invite further
research which could find possible therapeutical targets for
the treatment of human populations involuntarily expose
to the toxin.
Acknowledgements
The authors are grateful to Norma Cristalli for her
excellent technical assistance. The proof reading was per-
formed by Florencia Cobeaga and Colette O’Haire: This
study was partially supported by grants from CIC, SECYT
PICT 21227-53 and CONICET PIP 6099, Argentina.
Conflicts of interest
The authors declare no conflict of interest.
References
Aebi, H., 1984. Catalase in vitro. Methods Enzymol. 105, 121–126.
de Alaniz, M.J.T., Marra, C.A., 2003. Steroid hormones and fatty acid
desaturases. Prostaglandins Leukot. Essent. Fatty acids 68, 163–170.
Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W., Fu, P.C., 1974. Enzymatic
determination of total serum cholesterol. Clin. Chem. 20, 470–475.
Andrinolo, D., Sedan, D., Telese, L., Aura, C., Masera, S., Giannuzzi, L.,
Marra, C., Alaniz, M.T., 2008. Recovery after damage produced by sub-
chronic intoxication with the cyanotoxin microcystin LR. Toxicon 51,
457–467.
Asensi, M., Sastre, J., Pallardo, F.V., Garcı́a de la Asunción, J., Estrela, J.M.,
Viña, J., 1994. A high-performance liquid chromatography method for
measurement of oxidized glutathion in biological samples. Anal.
Biochem. 217, 323–328.
Barco, M., Lawton, L.A., Rivera, J., Caixach, J., 2005. Optimization of intra-
cellular microcystin extraction for their subsequent analysis by high-
performance liquid chromatography. J. Chromatogr. A 1074, 23–30.
Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein–dye
binding. Anal. Biochem. 72, 248–254.
Brigelius, R., Muckel, C., Akerboom, T.P., Sies, H., 1983. Identification and
quantitation of glutathione in hepatic protein mixed disulfides and its
relationship to glutathione disulfide. Biochem. Pharmacol. 32, 2529–
2534.
Buttris, J.L., Diplock, A.T., 1984. High-performance liquid chromatography
methods for vitamin E in tissues. Methods Enzymol. 105, 131–138.
Bury, N.R., Newlands, A.D., Eddy, F.B., Codd, G.A., 1998. In vivo and in vitro
intestinal transport of 3H-microcystin-LR, a cyanobacterial toxin, in
rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 42, 139–148.
Carlberg, I., Mannervick, B., 1985. Glutathione reductase. Methods Enzy-
mol. 113, 484–490.
Chen, T., Zhao, X., Liu, Y., Shi, Q., Hua, Z., Shen, P., 2004. Toxicology analysis of
immunomodulating nitric oxide, iNOS and cytokines mRNA in mouse
macrophages induced by microcystin-LR. Toxicology 197, 67–77.
Codd, G.A., 1996. Mechanism of action and healt effects associated with
cyanobacterial toxins. Toxicol. Lett. 88, 21.
Ding, W., Ong, C., 2003. Role of oxidative stress and mitochondrial
changes in cyanobacteria-induced apoptosis and hepatotoxicity.
FEMS Microbiol. Lett. 220, 1–7.
Eder, E., Wacker, W., Lutz, U., Nair, J., Fang, X., Bartsch, H., Beland, F.A.,
Schlatter, J., Lutz, W.K., 2006. Oxidative stress related DNA adducts in
the liver of female rats fed with sunflower-, rapeseed-, olive- or
coconut oil supplemented diets. Chem. Biol. Interact. 159, 81–89.
Falconer, I., 1994. Mechanism of Toxicity of Cyclic Peptide Toxins from
Blue-green Algae. In: Falconer, I. (Ed.), Algal Toxins in Seafood and
Drinking Water. Academic Press, Cambridge, pp. 177–187.
Falconer, I.R., 1999. An overview of problems caused by toxic blue-green
algae (cyanobacterial) in drinking and recreational waters. Environ.
Toxicol. 14, 5–12.
Flohé, L., Ötting, F., 1984. Superoxide dismutase assays. Methods Enzymol.
105, 93–104.
Gehringer, M.M., Shepard, E.G., Downing, T.G., Wiegand, C., Neilan, B.A.,
2004. An investigation into the detoxification of MC-LR by the
glutathione pathway in Balb/c mice. Int. J. Biochem. Cell. Biol. 36,
931–941.
Guzman, R.E., Solter, P.F., 1999. Hepatic oxidative stress following pro-
longed sublethal microcystin LR exposure. Toxicol. Pathol. 5, 582–588.
Guzman, R.E., Solter, P.F., 2002. Characterization of sublethal microcystin-
LR exposure in mice. Vet. Pathol. 39, 17–26.
Habig, W.H., Pabst, M.J., Jakoby, W.B., 1984. Glutathione-S-transferases.
The first enzymatic step in mercapturic acid formation. J. Biol. Chem.
249, 7130–7139.
Hermansky, S.J., Stohs, S.J., 1991. Effect of MC-LR (MCLR) on hepatic
microsomal membrane fluidity. Res. Comm. Chem. Pathol. Pharmacol.
72, 213–222.
Ito, E., Kondo, F., Harada, K., 2000. First report on the distribution of orally
administered microcystin-LR in mouse tissue using an immunos-
taining meted. Toxicon 38, 37–48.
Jochimsen, E.M., Carmichael, W.W., An, J.S., Cardo, D.M., Cookson, S.T.,
Holmes, C.E.M., Antunes, M.B.D., Melo, D.A., de Lyra, T.M., Barreto, V.S.
T., Azevedo, S., Jarvis, W.R., 1998. Liver failure and death after expo-
sure to microcystins at a hemodialysis center in Brazil. New Engl. J.
Med. 338, 873–878.
Lepage, G., Levy, E., Ronco, N., Galeano, N., Roy, C., 1989. Direct trasnses-
terification of plasma fatty acids for the diagnosis of essential fatty
acid deficiency in cystic fibrosis. J. Lipid Res. 30, 1483–1490.
Marra, C.A., de Alaniz, M.J.T., Brenner, R.R., 1986. Modulation of D6 and D5
rat liver microsomal desaturase activities by dexamethasone-induced
factor. Biochim. Biophys. Acta 879, 388–393.
Marra, C.A., de Alaniz, M.J.T., 1992. Incorporation and metabolic conver-
sion of saturated and unsaturated fatty acids in SK-Hep1 human
hepatoma cells in culture. Mol. Cell. Biochem. 117, 107–118.
Marra, C.A., Zaidenmerg, A., de Alaniz, M.J.T., Buschiazzo, H., 2002. The
restoring effect of trifluralin and benznidazole on the abnormal fatty-
acid pattern induced by Trypanosoma cruzi in the liver microsomes of
infected mice. Ann. Trop. Med. Pharmacol. 96, 249–264.
Martı́nez, M., Ballabriga, A., 1987. Effect of parenteral nutrition with high
doses of linoleate on the developing human liver and brain. Lipids 22,
133–138.
Milutinovic, A., Zivin, M., Zorc-Pleskovic, R., Sedmak, B., Suput, D., 2003.
Nephrotoxic effects of chronic administration of microcystins-LR and
-YR. Toxicon 42, 281–288.
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